Ranok is a privately held, clinical-stage biopharmaceutical company that is pioneering CHAMP®, an innovative approach to targeted protein degradation for the discovery and development of novel therapeutics. Our R&D team brings deep biological insight and chemistry expertise to rapidly identify and advance CHAMP® degraders for a variety of important disease targets, with the goal to create transformative medicines that benefit patients around the world suffering from cancer and other serious diseases. For more information, please visit the company website at www.ranoktherapetics.com or follow us at LinkedIn and Twitter @RanokTx.
Company Details
- Employees
- 11
- Founded
- -
- Address
- 303 Wyman Street,
- Industry
- Biotechnology
- Website
- http://www.ranoktherapetics.com
- Keywords
- to rapidly identify and advance CHAMP® degraders for a variety of important disease targets.
- HQ
- Waltham, Massachusetts
Ranok Therapeutics Questions
Ranok Therapeutics's website is http://www.ranoktherapetics.com
Ranok Therapeutics's LinkedIn profile is https://www.linkedin.com/company/ranok-therapeutics
Ranok Therapeutics has
11 employees.
View email and phone details for 11
employees at Ranok Therapeutics.
Ranok Therapeutics's industry is
Biotechnology
Ranok Therapeutics's top competitors are
Alesta Therapeutics,
Photys Therapeutics,
Treeline Biosciences,
Paq Therapeutics,
Nested Therapeutics,
Nexo Therapeutics,
Recludix Pharma,
Auron Therapeutics, Inc.,
Montis Biosciences,
Solu Therapeutics.
Ranok Therapeutics's categories are Biotechnology
Ranok Therapeutics's founding year is 2018
